DarioHealth Corp. (DRIO) Institutional Ownership

Ownership Summary

DarioHealth Corp. (NASDAQ:DRIO) currently has 17 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• These investors collectively held 11.5% of the company's total shares outstanding in December 2025, down from 13.3% in September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 19.33%, with a year-over-year a decrease of 58.54% in the count of filers.
• A review of institutional activity for DarioHealth shows 8 of 17 filers increasing their positions, while 2 reduced their stake, and 7 remained unchanged.
• The total number of shares held by institutions in DarioHealth increased to 735.35K as of December 2025, a net change of up by 119.14K shares quarter on quarter, and up 347.02K shares year over year.
• Nantahala Capital Management, LLC continues to be the largest institutional holder of DarioHealth as of December 31, 2025, with a position of 563.23K shares, representing 8.84% of the company's outstanding stock.
• Among the most significant buyers of DarioHealth during December 2025 were VANGUARD GROUP INC (68.90K), GEODE CAPITAL MANAGEMENT, LLC (31.06K), BlackRock, Inc. (16.34K), Kestra Advisory Services, LLC (3.10K), UBS Group AG (106).
• Leading sellers of DarioHealth stock in December 2025 included Tower Research Capital LLC (TRC) (502), Nantahala Capital Management, LLC (1).
• The top 10 institutional holders of DarioHealth for the quarter ending December 2025 included Nantahala Capital Management, LLC (563.23K), VANGUARD GROUP INC (99.30K), GEODE CAPITAL MANAGEMENT, LLC (49.57K), BlackRock, Inc. (18.82K), Kestra Advisory Services, LLC (3.10K), Tower Research Capital LLC (TRC) (409), TRUST CO OF TOLEDO NA /OH/ (352), UBS Group AG (245), ROYAL BANK OF CANADA (129), SBI Securities Co., Ltd. (71).